Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinoma
Background and objectives: Apoptosis, a process of cell death, is inhibited by the B-cell lymphoma 2 protein, leading to the prolonged survival of cells. Participation of Bcl-2 in starting and advancement of endometrial carcinoma remains inconclusive, with varying results observed. The aims of this...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kurdistan Higher Council Of Medical Specialties
2024-09-01
|
| Series: | Advanced Medical Journal |
| Subjects: | |
| Online Access: | https://amj.khcms.edu.krd/index.php/main/article/view/477 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850147903451955200 |
|---|---|
| author | Hozan Dler Dhahir Jalal Ali Jalal Zheen Othman Hama Faraj |
| author_facet | Hozan Dler Dhahir Jalal Ali Jalal Zheen Othman Hama Faraj |
| author_sort | Hozan Dler Dhahir |
| collection | DOAJ |
| description |
Background and objectives: Apoptosis, a process of cell death, is inhibited by the B-cell lymphoma 2 protein, leading to the prolonged survival of cells. Participation of Bcl-2 in starting and advancement of endometrial carcinoma remains inconclusive, with varying results observed. The aims of this study were to assess the frequency of B-cell lymphoma 2 expression in endometrial carcinoma, and to investigate the connection between B-cell lymphoma 2 expression with some clinicopathological parameters.
Methods: A retrospective study was carried out for seventy-eight formalin fixed paraffin embedded blocks of total abdominal hysterectomy specimens diagnosed as endometrial carcinoma, which were randomly obtained from a private laboratory and Rizgary teaching hospital laboratory in Erbil city during June 2021-June 2022. In this study, endometrial carcinoma cases were subjected to the utilization of B-cell lymphoma 2 gene, which is a Mouse monoclonal antibody, and its expression was evaluated.
Results: The expression of Bcl-2 was observed in 61.5% of the studied cases. The majority (93.6%) of EC cases were of low grade, although Bcl-2 expression was observed at a greater frequency (64.4%) in low-grade endometrial carcinoma, but there was no significant association. Additionally, no statistically significant correlation was found between B-cell lymphoma 2 gene expression and other clinicopathological parameters like, age, myometrial invasion, lympho-vascular invasion, lymph node status and tumor stage.
Conclusion: Bcl-2 was expressed in 61.5% of the studied cases with no significant association with any of the variables, additional research is necessary to assess the expression of B-cell lymphoma 2 gene in relation to endometrial carcinoma invasion and metastasis.
|
| format | Article |
| id | doaj-art-a50d4a571aaf46f5a6a0d724cda80ddc |
| institution | OA Journals |
| issn | 2958-8979 2957-3580 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Kurdistan Higher Council Of Medical Specialties |
| record_format | Article |
| series | Advanced Medical Journal |
| spelling | doaj-art-a50d4a571aaf46f5a6a0d724cda80ddc2025-08-20T02:27:24ZengKurdistan Higher Council Of Medical SpecialtiesAdvanced Medical Journal2958-89792957-35802024-09-019310.56056/amj.2024.274478Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinomaHozan Dler Dhahir0Jalal Ali Jalal1Zheen Othman Hama Faraj2SHO of Histopathology in Rizgary Hospital, trainee of Histopathology at the Kurdistan higher council of medical specialties (KHCMS), Erbil.Professor of pathology at college of medicine-Hawler medical university, Erbillecturer at college of medicine-Hawler medical university, Erbil. Background and objectives: Apoptosis, a process of cell death, is inhibited by the B-cell lymphoma 2 protein, leading to the prolonged survival of cells. Participation of Bcl-2 in starting and advancement of endometrial carcinoma remains inconclusive, with varying results observed. The aims of this study were to assess the frequency of B-cell lymphoma 2 expression in endometrial carcinoma, and to investigate the connection between B-cell lymphoma 2 expression with some clinicopathological parameters. Methods: A retrospective study was carried out for seventy-eight formalin fixed paraffin embedded blocks of total abdominal hysterectomy specimens diagnosed as endometrial carcinoma, which were randomly obtained from a private laboratory and Rizgary teaching hospital laboratory in Erbil city during June 2021-June 2022. In this study, endometrial carcinoma cases were subjected to the utilization of B-cell lymphoma 2 gene, which is a Mouse monoclonal antibody, and its expression was evaluated. Results: The expression of Bcl-2 was observed in 61.5% of the studied cases. The majority (93.6%) of EC cases were of low grade, although Bcl-2 expression was observed at a greater frequency (64.4%) in low-grade endometrial carcinoma, but there was no significant association. Additionally, no statistically significant correlation was found between B-cell lymphoma 2 gene expression and other clinicopathological parameters like, age, myometrial invasion, lympho-vascular invasion, lymph node status and tumor stage. Conclusion: Bcl-2 was expressed in 61.5% of the studied cases with no significant association with any of the variables, additional research is necessary to assess the expression of B-cell lymphoma 2 gene in relation to endometrial carcinoma invasion and metastasis. https://amj.khcms.edu.krd/index.php/main/article/view/477ApoptosisB-cell lymphoma 2 geneEndometrial carcinomaImmunohistochemistry |
| spellingShingle | Hozan Dler Dhahir Jalal Ali Jalal Zheen Othman Hama Faraj Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinoma Advanced Medical Journal Apoptosis B-cell lymphoma 2 gene Endometrial carcinoma Immunohistochemistry |
| title | Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinoma |
| title_full | Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinoma |
| title_fullStr | Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinoma |
| title_full_unstemmed | Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinoma |
| title_short | Immunohistochemical expression of B-cell lymphoma 2 gene -Bcl-2 in endometrial carcinoma |
| title_sort | immunohistochemical expression of b cell lymphoma 2 gene bcl 2 in endometrial carcinoma |
| topic | Apoptosis B-cell lymphoma 2 gene Endometrial carcinoma Immunohistochemistry |
| url | https://amj.khcms.edu.krd/index.php/main/article/view/477 |
| work_keys_str_mv | AT hozandlerdhahir immunohistochemicalexpressionofbcelllymphoma2genebcl2inendometrialcarcinoma AT jalalalijalal immunohistochemicalexpressionofbcelllymphoma2genebcl2inendometrialcarcinoma AT zheenothmanhamafaraj immunohistochemicalexpressionofbcelllymphoma2genebcl2inendometrialcarcinoma |